RSS Search

News  Feeds  Tags  Search Shortcuts

FeedsFarm.com > Can healthcare systems afford Herceptin for early breast cancer?

Can healthcare systems afford Herceptin for early breast cancer?

30th Nov 2005, 03:19 GMT

New research into the cost of using the breast cancer drug Herceptin warns that healthcare authorities and the organisations advising them should not rush to prescribe it for early breast cancer without working out extremely carefully the budget implications and cost-effectiveness of the drug. In a Belgian study published (Wednesday 30 November) in Annals of Oncology[1], health economist Mattias Neyt said that if the drug turns out to be as powerful in early breast cancer as preliminary results show, then it may well be cost effective for certain sub-groups.

View full story at www.keralanext.com

Can healthcare systems afford Herceptin for early breast cancer? related news:

Latest news from KeralaNext: Science: